Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial

BACKGROUND: Early heart failure prevention is central in patients with type 2 diabetes, and mineralocorticoid receptor antagonists (MRAs) have shown to improve prognosis. We investigated the effect of high-dose MRA, eplerenone, on cardiac function and structure in patients with type 2 diabetes and e...

Descripción completa

Detalles Bibliográficos
Autores principales: H. Brandt-Jacobsen, Niels, Johansen, Marie Louise, Rasmussen, Jon J., Dalsgaard, Morten, Kumler, Thomas, Faber, Jens, Rossignol, Patrick, Schou, Morten, Kistorp, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064675/
https://www.ncbi.nlm.nih.gov/pubmed/37003987
http://dx.doi.org/10.1186/s12872-023-03183-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064675/
https://www.ncbi.nlm.nih.gov/pubmed/37003987
http://dx.doi.org/10.1186/s12872-023-03183-1

Ejemplares similares